Literature DB >> 15780723

Assessment of vaccine coverage following the introduction of a publicly funded pneumococcal vaccine program for the elderly in Victoria, Australia.

Ross M Andrews1.   

Abstract

In 1998, a publicly funded pneumococcal vaccine program was introduced for persons aged > or = 65 years in Victoria, Australia. In 2000, vaccine coverage over the previous 5 years was assessed through a telephone survey of 385 randomly selected subjects aged > or = 65 years. Self-reported pneumococcal vaccine coverage within the previous 5 years was 46.0% (95% CI 40.5-51.6). Self-report was validated against the medical records of the nominated provider for 278 (72%) subjects. Among this subgroup, self-reported coverage was 51.1% but was 57.9% according to medical records (positive predictive value 91.5%, negative predictive value 77.2%, sensitivity 80.7%, specificity 89.7%). After accounting for response bias among those subjects for whom self-report was not validated, the revised estimate of pneumococcal vaccine coverage within the previous 5 years was 50.5% (95% CI 44.8-56.1). Comparison of vaccine coverage over time suggests the introduction of the publicly funded program in Victoria has dramatically increased coverage among the elderly.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780723     DOI: 10.1016/j.vaccine.2004.11.039

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors?

Authors:  S J Rolnick; E D Parker; J D Nordin; B D Hedblom; F Wei; T Kerby; J M Jackson; A L Crain; G Euler
Journal:  Vaccine       Date:  2013-06-24       Impact factor: 3.641

2.  Validation of influenza and pneumococcal vaccine status in adults based on self-report.

Authors:  P Mangtani; A Shah; J A Roberts
Journal:  Epidemiol Infect       Date:  2006-06-02       Impact factor: 2.451

3.  Factors associated with pneumococcal vaccination among an urban elderly population in China.

Authors:  Shijun Liu; Erping Xu; Yan Liu; Yuyang Xu; Jun Wang; Jian Du; Xiaoping Zhang; Xinren Che; Wenwen Gu
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Adherence and factors associated with influenza vaccination among subjects with asthma in Spain.

Authors:  J M Santos-Sancho; A López-de Andrés; I Jimenez-Trujillo; V Hernández-Barrera; P Carrasco-Garrido; P Astasio-Arbiza; R Jimenez-Garcia
Journal:  Infection       Date:  2013-02-12       Impact factor: 3.553

5.  Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.

Authors:  Angela Domínguez; Jesús Castilla; Pere Godoy; Miguel Delgado-Rodríguez; Marc Saez; Núria Soldevila; Jenaro Astray; José María Mayoral; Vicente Martín; José María Quintana; Fernando González-Candelas; Juan Carlos Galán; Sonia Tamames; Ady Castro; Maretva Baricot; Olatz Garín; Tomas Pumarola
Journal:  Hum Vaccin Immunother       Date:  2013-04-01       Impact factor: 3.452

6.  Vaccination behaviour influences self-report of influenza vaccination status: a cross-sectional study among health care workers.

Authors:  Anna Llupià; Alberto L García-Basteiro; Guillermo Mena; José Ríos; Joaquim Puig; José M Bayas; Antoni Trilla
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

7.  Measuring parents' acceptance of non-national immunization program vaccines for children and its influencing factors during the COVID-19 pandemic in Shanghai, China.

Authors:  Linlin Wu; Zhuoying Huang; Xiang Guo; Jiechen Liu; Xiaodong Sun
Journal:  Hum Vaccin Immunother       Date:  2022-06-21       Impact factor: 4.526

8.  Outpatient-based pneumococcal vaccine campaign and survey of perceptions about pneumococcal vaccination in patients and doctors.

Authors:  Joon Young Song; Hee Jin Cheong; Jung Yeon Heo; Ji Yun Noh; Yu Bin Seo; In Seon Kim; Won Suk Choi; Woo Joo Kim
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

9.  Cross-sectional study on attitudes among general practitioners towards pneumococcal vaccination for middle-aged and elderly population in Hong Kong.

Authors:  Lancelot W H Mui; Alvin Y S Chan; Albert Lee; John Lee
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

10.  Influenza and pneumococcal vaccination in Australian adults: a systematic review of coverage and factors associated with uptake.

Authors:  Amalie Dyda; Surendra Karki; Andrew Hayen; C Raina MacIntyre; Robert Menzies; Emily Banks; John M Kaldor; Bette Liu
Journal:  BMC Infect Dis       Date:  2016-09-26       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.